humanitarian
Archived signal
Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 26, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 26, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 28, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 28, Status: AuthorisedEMA What Is NewVeterinary medicines European public assessment report (EPAR): Scovella, velagliflozin, Status: OpinionEMA What Is NewVeterinary medicines European public assessment report (EPAR): Credelio Quattro, lotilaner,moxidectin,pyrantel,praziquantel, Status: OpinionEMA What Is NewVeterinary medicines European public assessment report (EPAR): Laverdia, verdinexor, Status: OpinionEMA What Is NewVeterinary medicines European public assessment report (EPAR): Scovella, velagliflozin, Status: OpinionEMA What Is NewVeterinary medicines European public assessment report (EPAR): Credelio Quattro, lotilaner,moxidectin,pyrantel,praziquantel, Status: OpinionEMA What Is NewVeterinary medicines European public assessment report (EPAR): Laverdia, verdinexor, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 19, Status: Authorised2 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources